Clinical Research and Trials


Marinus Pharmaceuticals is conducting a clinical trial in children with CDKL5 to evaluate a compound it is developing for epilepsy, called ganaxolone. If you are interested in participating in the clinical trial, please speak with your doctor and visit Clinical Trial for CDKL5 to learn more about the trial as well as inclusion and exclusion criteria and who to contact to participate or if you have any questions.
This trial was initially for PCDH19, another rare epilepsy, but has expanded to include CDKL5.

Current enrolling sites are:

  • Sacramento, CA
  • San Francisco, CA
  • Atlanta, GA
  • Indianapolis, IN
  • Hackensack, NJ
  • Livingston, NJ
  • Rome, Italy

*IFCR is passing this information along to you for information purposes, please check with your doctor first to see if your child should participate.